| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | SVP, CCO | Common Stock | 173,841 | $212,590 | $1.22 | 01 Mar 2022 | Direct |
| Akebia Therapeutics, Inc. | SVP, CCO | Employee Stock Option (Right to buy) | 200,000 | 28 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | 28 Feb 2022 | 5 | -$28,515 | 4 | SVP, CCO | 02 Mar 2022, 20:10 |